Vericel (NASDAQ:VCEL) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS
Vericel (NASDAQ:VCEL – Get Free Report) released its quarterly earnings results on Wednesday. The biotechnology company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.02, Briefing.com reports. The company had revenue of $45.92 million during the quarter, compared to the consensus estimate of $42.14 million. Vericel had […]